Taken together, all these findings suggest that changes in Rho-A and Rac-1 activity could play an important role in the pathogenesis of renal diseases associated with high circulating levels of FGF-2 and VEGF-A [11, 14, 69, 70]. This evidence concerns the gene RHOA and kidney disorder.